Pendal Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $222M | Sell |
432,785
-38,588
| -8% | -$19.8M | 1.92% | 11 |
|
2022
Q3 | $214M | Buy |
471,373
+39,549
| +9% | +$18M | 2.08% | 11 |
|
2022
Q2 | $208M | Buy |
431,824
+209,746
| +94% | +$101M | 2.05% | 11 |
|
2022
Q1 | $109M | Buy |
222,078
+44,238
| +25% | +$21.7M | 0.9% | 43 |
|
2021
Q4 | $82.4M | Sell |
177,840
-66,216
| -27% | -$30.7M | 0.66% | 49 |
|
2021
Q3 | $91M | Buy |
244,056
+1,328
| +0.5% | +$495K | 0.75% | 51 |
|
2021
Q2 | $92.7M | Buy |
242,728
+239,378
| +7,146% | +$91.4M | 0.85% | 47 |
|
2021
Q1 | $1.2M | Sell |
3,350
-922
| -22% | -$331K | 0.01% | 292 |
|
2020
Q4 | $1.37M | Sell |
4,272
-12,121
| -74% | -$3.89M | 0.01% | 254 |
|
2020
Q3 | $4.4M | Buy |
16,393
+3,469
| +27% | +$932K | 0.05% | 105 |
|
2020
Q2 | $3.4M | Buy |
12,924
+1,603
| +14% | +$422K | 0.05% | 130 |
|
2020
Q1 | $2.57M | Sell |
11,321
-10,358
| -48% | -$2.35M | 0.04% | 138 |
|
2019
Q4 | $6.55M | Buy |
21,679
+19,872
| +1,100% | +$6M | 0.09% | 111 |
|
2019
Q3 | $434K | Sell |
1,807
-35,920
| -95% | -$8.62M | 0.01% | 366 |
|
2019
Q2 | $10.6M | Sell |
37,727
-6,856
| -15% | -$1.93M | 0.15% | 71 |
|
2019
Q1 | $12.8M | Hold |
44,583
| – | – | 0.18% | 67 |
|
2018
Q4 | $11.7M | Buy |
44,583
+9,727
| +28% | +$2.55M | 0.19% | 76 |
|
2018
Q3 | $9.55M | Sell |
34,856
-1,809
| -5% | -$496K | 0.13% | 94 |
|
2018
Q2 | $8.73M | Sell |
36,665
-8,989
| -20% | -$2.14M | 0.11% | 120 |
|
2018
Q1 | $10M | Hold |
45,654
| – | – | 0.13% | 113 |
|
2017
Q4 | $10.3M | Buy |
45,654
+10,109
| +28% | +$2.27M | 0.13% | 116 |
|
2017
Q3 | $6.76M | Sell |
35,545
-7,370
| -17% | -$1.4M | 0.09% | 151 |
|
2017
Q2 | $8.07M | Buy |
+42,915
| New | +$8.07M | 0.12% | 134 |
|